Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ondine Biomed (OBI) Regulatory News

Date Source Headline
4th Nov 2022 7:00 am RNS PDMR Dealing
31st Oct 2022 11:18 am RNS Ondine CTO receives Lifetime Achievement Award
28th Oct 2022 7:00 am RNS PDMR Dealing
19th Oct 2022 12:07 pm RNS Ondine presents new efficacy data against MRSA
19th Oct 2022 11:36 am RNS Steriwave™ cuts SSI risk by 47% at major hospital
11th Oct 2022 7:00 am RNS Investor Presentation
27th Sep 2022 7:00 am RNS Interim results for the six months to 30 June 2022
23rd Sep 2022 9:00 am RNS The Ottawa Hospital pilots nasal disinfection
20th Sep 2022 9:34 am RNS New research presented on photodisinfection
7th Sep 2022 12:30 pm RNS Ondine’s photodisinfection kills ESKAPE pathogens
6th Sep 2022 7:00 am RNS Ondine reports successful US Phase 2 trial data
31st Aug 2022 10:49 am RNS Nature reports Ondine therapy suppresses COVID-19
16th Aug 2022 7:00 am RNS Ondine appoints RBC and Singer as joint brokers
8th Aug 2022 10:02 am RNS Ondine completes US Phase II trial recruitment
26th Jul 2022 7:00 am RNS Completion of Nominated Adviser due diligence
22nd Jul 2022 7:00 am RNS Issue of Equity
19th Jul 2022 7:00 am RNS Ondine completes successful SARS-CoV-2 trial
8th Jun 2022 7:00 am RNS Result of AGM
7th Jun 2022 7:00 am RNS Posting of annual report
19th May 2022 7:00 am RNS Full Year Results to 31 December 2021
17th May 2022 7:00 am RNS Notice of AGM
10th May 2022 10:30 am RNS WHO calls for better infection prevention
27th Apr 2022 4:30 pm RNS Appointment of Nominated Adviser
5th Apr 2022 7:00 am RNS Photodisinfection effective against SARS-CoV-2
21st Feb 2022 7:00 am RNS Grant of Options and PDMR Dealing
7th Feb 2022 7:00 am RNS Ondine treats first patients in Phase 2 FDA trial
20th Dec 2021 7:00 am RNS Ondine and University of Navarra initiate clinical
15th Dec 2021 7:00 am RNS Ondine Biomedical appoints Professor Trevor Jones
7th Dec 2021 7:00 am RNS Ondine Biomedical appoints new Board of Directors
6th Dec 2021 7:00 am RNS Ondine Biomedical announces AIM market listing
FTSE 100 Latest
Value8,275.66
Change0.00